Submit manuscript...
Journal of
eISSN: 2373-6410

Neurology & Stroke

Editorial Volume 2 Issue 3

Disease Propagation in Amyotrophic Lateral Sclerosis: Insights and Hopes

Gianni Soraru

Department of Neurosciences, Neuromuscular Center, University of Padova, Italy

Correspondence: Gianni Soraru, MD, PHD, Motor Neuron Disease Clinic, Department of Neurosciences, University of Padova, 35128 Padova, Italy

Received: May 04, 2015 | Published: May 8, 2015

Citation: Soraru G (2015) Disease Propagation in Amyotrophic Lateral Sclerosis: Insights and Hopes. J Neurol Stroke 2(3): 00052. DOI: 10.15406/jnsk.2015.02.00052

Download PDF


ALS: Amyotrophic lateral sclerosis, UMN: Upper Motor Neurons, LMN: Lower Motor Neurons, SOD1: Superoxide Dismutase 1


Amyotrophic lateral sclerosis (ALS) is a devastating degenerative disorder characterized by a progressive decline of upper (UMN) and lower motor neurons (LMN), leading to muscle wasting and finally death. The cause of the disease is still unknown, with the exception of cases due to ALS-related gene mutations. The phenotypes of ALS are heterogeneous, being different ALS subtypes recognized according to the extent and site of involved UMN and LMN.1 Although the disease evolves towards a widespread involvement of motor neurons in most patients, survival is significantly influenced by distinct phenotypes.1 The presence of misfolded protein aggregates, mainly composed of transactive response DNA binding protein of 43 kDa (TDP-43), and is the pathological hallmark of the disease regardless the subtype .2

A feature that is common to all ALS patients is that motor manifestations at clinical onset are focal and they appear randomly in the body.3 Once the focal onset in ALS occurs, motor impairment appears to spread outwardto contiguous body regions. This suggests that the pathological process starting in a discrete region of motor neuron system propagates to adjacent motor neurons. When a diffuse motor neuron involvement is observed at onset, a multifocal onset rather than a noncontiguous pattern of disease propagation may be postulated.4

To explain the focality and neuroanatomic progression of the disease, a prion-like propagation of altered proteins has been argued. According to this hypothesis, misfolded proteins could induce a self-perpetuating process that leads to amplification, abnormal protein-induced conversion of normally configured proteins to misfolded proteins, and spreading of the pathological proteinsfrom the site of disease onset to the neighboring cells.5 TDP-43, as well as superoxide dismutase 1 (SOD1), misfolding and aggregating in ALS cases linked to SOD1 mutations, have prion-like properties. The ubiquitinated and phosphorylated C-terminal fragments of TDP-43 within cytoplasmic inclusions of ALS neural cells act as seeds and can template their own self-aggregation.6 In vitro studies have shown that SOD1 misfolding can be transmitted not only from protein to protein but also from cell to cell in a prion-like manner .7 It is matter of debate whether propagation of neurodegeneration occurs by contiguous spread, i.e., cell-to-cell independent of synaptic connection, or based onneuronal networks, i.e. via synaptic connectivity.8 Anyway, both types of propagations could be involved in ALS at the same time. Whatever the mechanism, the initial degeneration has been observed to maximally involve UMN and LMN innervating the same body region. According to longitudinal and cross-sectional studies, subsequent neurodegeneration spreads medially and laterally at the UMN level and to the contralateral side at the LMN level, in an overall rostral to caudal direction.

There is currently no cure available to treat ALS. Understanding the mechanisms underlying the neuroanatomical spread of ALS pathology could represent analternative target for developing disease-modifying agents in ALS.



Conflicts of interest



Creative Commons Attribution License

©2015 Soraru. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.